Citigroup’s Epizyme, Inc EPZM Stock Holding History

Citigroup’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-8,000	Closed	-$182K	–	7385
2014 Q1	$182K	Buy	+8,000	New	+$242K	﹤0.01%	4423

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Citigroup's EPZM Position: Q3 2022 in Review

Citigroup sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 461,240 shares — an estimated $678K sold.

Citigroup first reported a position in EPZM in Q3 2013 and held it in 36 quarters. The position peaked at $10.4M in Q1 2014. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Citigroup reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Citigroup sold 461,240 Epizyme, Inc shares in Q3 2022, an estimated $678K.
Citigroup first reported a position in Epizyme, Inc in Q3 2013 and held it in 36 quarters.
Citigroup's Epizyme, Inc position peaked at $10.4M in Q1 2014.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.